# Kura Oncology, Inc.: Form 8-K, filed Jul 29, 2026

- Company: [Kura Oncology, Inc.](/companies/kura.md) (CIK 1422143)
- Form: 8-K
- Filed: 2026-07-29
- Accepted by EDGAR: Jul 29, 2026, 17:06 ET
- Period: 2026-07-24
- Accession: 0001193125-26-324202
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1422143/000119312526324202/d53075d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1422143/000119312526324202/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1422143/000119312526324202/d53075d8k.htm

Filed Jul 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-324202. Last ingested by Listed: Nov 11, 2026, 03:30 ET. No prices; not investment advice.
